What is the share price of KOBO Biotech Ltd (KOBO) today?

The share price of KOBO as on 16th July 2025 is ₹2.64. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on KOBO Biotech Ltd (KOBO) share?

The past returns of KOBO Biotech Ltd (KOBO) share are Past 1 week: 10.00% Past 1 month: N/A% Past 3 months: -8.62% Past 6 months: -29.14% Past 1 year: -37.35% Past 3 years: -43.13% Past 5 years: -32.40%

What are the peers or stocks similar to KOBO Biotech Ltd (KOBO)?

The peers or stocks similar to KOBO Biotech Ltd (KOBO) include: KOBO Biotech Ltd Sun Pharmaceutical Industries Ltd Cipla Ltd Torrent Pharmaceuticals Ltd Mankind Pharma Ltd Dr Reddy's Laboratories Ltd

What is the market cap of KOBO Biotech Ltd (KOBO) share?

Market capitalization, short for market cap , is the market value of a publicly traded company's outstanding shares. The market cap of KOBO Biotech Ltd (KOBO) is ₹6.31 Cr as of 16th July 2025.

What is the 52 week high and low of KOBO Biotech Ltd (KOBO) share?

The 52-week high of KOBO Biotech Ltd (KOBO) is ₹4.56 and the 52-week low is ₹2.32.

What is the PE and PB ratio of KOBO Biotech Ltd (KOBO) stock?

The P/E (price-to-earnings) ratio of KOBO Biotech Ltd (KOBO) is -1.28. The P/B (price-to-book) ratio is -0.05.

Which sector does KOBO Biotech Ltd (KOBO) belong to?

KOBO Biotech Ltd (KOBO) belongs to the Health Care sector & Pharmaceuticals sub-sector.

How to buy KOBO Biotech Ltd (KOBO) shares?

You can directly buy KOBO Biotech Ltd (KOBO) shares on Tickertape. Simply sign up, connect your demat account and place your order.

KOBO Biotech Ltd

KOBO Share Price

2.640.38% (-0.01)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹6 cr, stock is ranked 4,892

High Risk

Stock is 4.28x as volatile as Nifty

KOBO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹6 cr, stock is ranked 4,892

High Risk

Stock is 4.28x as volatile as Nifty

KOBO Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
-1.25	-0.05	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
37.80	6.51	0.80%

KOBO Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

KOBO Company Profile

Kobo Biotech Limited is an India-based company focused on manufacturing active pharmaceutical ingredients (APIs) and bulk drugs, currently undergoing corporate insolvency resolution.

KOBO Similar Stocks (Peers)

Compare with peers Compare with peers

KOBO Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

37.93

1Y Return

8.91%

Buy Reco %

84.85

Cipla Ltd

CIPLA

PE Ratio

22.84

1Y Return

1.73%

Buy Reco %

68.75

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

60.91

1Y Return

16.45%

Buy Reco %

70.83

Mankind Pharma Ltd

MANKIND

PE Ratio

54.95

1Y Return

23.38%

Buy Reco %

81.25

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

18.55

1Y Return

7.22%

Buy Reco %

48.39

Compare with Peers

KOBO Forecast

KOBO Forecasts

KOBO

Income

Balance Sheet

Cash Flow

KOBO Income Statement

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	TTM
Total Revenue	32.96	6.00	0.04	0.03	0.03	0.04	0.02	0.02	0.02	0.02
Raw Materials	11.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.87	0.99
Power & Fuel Cost	2.03	0.28	0.24	0.31	0.42	0.28	0.10	0.12
Employee Cost	4.27	3.11	2.42	2.08	1.80	1.39	0.72	0.23
Selling & Administrative Expenses	0.96	0.16	0.11	0.21	0.14	0.15	0.11	0.14
Operating & Other expenses	9.37	0.49	0.25	1.30	-1.67	0.97	9.57	1.01
EBITDA	5.23	1.96	-2.98	-3.87	-0.66	-2.75	-10.48	-1.48	-0.85	-0.97
Depreciation/Amortization	7.31	6.78	6.44	6.15	5.88	5.64	4.61	4.07	4.07	4.07
PBIT	-2.08	-4.82	-9.42	-10.02	-6.54	-8.39	-15.09	-5.55	-4.92	-5.04
Interest & Other Items	14.37	14.41	14.50	14.44	14.47	10.84	0.13	0.00	0.00	—
PBT	-16.45	-19.23	-23.92	-24.46	-21.01	-19.23	-15.22	-5.55	-4.92	-5.04
Taxes & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Income	-16.45	-19.23	-23.92	-24.46	-21.01	-19.23	-15.22	-5.55	-4.92	-5.04
EPS	-7.12	-8.09	-10.04	-10.27	-8.82	-8.07	-6.39	-2.33	-2.07	-2.12
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Quarter		mar 2022		jun 2022		sep 2022		dec 2022		mar 2023	jun 2023	sep 2023	dec 2023	mar 2024	jun 2024
Total Revenue	0.00	0.02	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.02
Operating & Other expenses	9.24	0.33	0.21	0.17	0.79	0.23	0.20	0.20	0.25	0.34
EBITDA	-9.24	-0.31	-0.21	-0.17	-0.79	-0.21	-0.20	-0.20	-0.25	-0.32
Depreciation/Amortization	1.18	1.15	0.89	1.03	1.00	1.01	1.02	1.03	1.01	1.01
PBIT	-10.42	-1.46	-1.10	-1.20	-1.79	-1.22	-1.22	-1.23	-1.26	-1.33
Interest & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PBT	-10.42	-1.46	-1.10	-1.20	-1.79	-1.22	-1.22	-1.23	-1.26	-1.33
Taxes & Other Items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	-10.42	-1.46	-1.10	-1.20	-1.79	-1.22	-1.22	-1.23	-1.26	-1.33
EPS	-4.37	-0.62	-0.46	-0.50	-0.75	-0.51	-0.51	-0.52	-0.53	-0.56

Financial Year		FY 2014		FY 2015		FY 2016		FY 2017		FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023
Cash from Operating Activities	11.02	19.32	5.62	32.30	31.47	20.95	14.48	2.51	93.76	0.87
Cash from Investing Activities	-4.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	25.09	0.00
Cash from Financing Activities	-7.00	-20.50	-5.27	-32.76	-31.47	-20.95	-14.47	-1.08	-120.28	-0.87
Net Change in Cash	-0.69	-1.18	+0.35	-0.46	+0.00	+0.00	+0.01	+1.43	-1.43	+0.00
Changes in Working Capital	+15.29	+26.18	+0.39	+30.36	+34.45	+24.82	+15.13	+5.26	+104.25	+2.35
Capital Expenditures	4.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Free Cash Flow	6.31	19.32	5.62	32.30	31.47	20.95	14.48	2.51	93.76	0.87

KOBO Company Updates

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

FY 2015FY 2015

Annual report

PDF

FY 2014FY 2014

Annual report

PDF

KOBO Stock Peers

KOBO Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation-basic on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
KOBO Biotech Ltd	-1.28	-0.05	—
Sun Pharmaceutical Industries Ltd	37.93	5.72	0.93%
Cipla Ltd	22.84	3.85	1.07%
Torrent Pharmaceuticals Ltd	60.91	15.34	0.93%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
KOBO Biotech Ltd	Pro
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
KOBO Biotech Ltd	58.74%	55.38	Pro
Sun Pharmaceutical Industries Ltd	20.75%	70.63
Cipla Ltd	22.90%	43.10
Torrent Pharmaceuticals Ltd	24.30%	69.12

KOBO Stock Price Comparison

Compare KOBO with any stock or ETF

KOBO

KOBO Holdings

KOBO Shareholdings

KOBO Promoter Holdings Trend

KOBO Institutional Holdings Trend

KOBO Shareholding Pattern

KOBO Shareholding History

Foreign Institutions

KOBO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing KOBO stock

Looks like this stock is not in any smallcase yet.

KOBO Events

KOBO Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

KOBO Dividend Trend

KOBO Upcoming Dividends

No upcoming dividends are available

KOBO Past Dividends

Cash Dividend

Ex DateEx DateSep 21, 2012

Final

Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 21, 2012

Cash Dividend

Ex DateEx DateJul 22, 2011

Final

Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 22, 2011

KOBO Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Company Update

Announced OnMay 23, 2025

Kobo Biotech Ltd-$ - 531541 - Corporate

Kobo Biotech Ltd-$ - 531541 - Corporate Download

Link

Download

Announced On

May 23, 2025

Company Update

Announced OnMay 23, 2025

Kobo Biotech Ltd-$ - 531541 - Corporate

Kobo Biotech Ltd-$ - 531541 - Corporate Download

Link

Download

Announced On

May 23, 2025

KOBO Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

KOBO Stock News & Opinions

Earnings

Kobo Biotech reports standalone net loss of Rs 1.33 crore in the June 2024 quarter

Net Loss of Kobo Biotech reported to Rs 1.33 crore in the quarter ended June 2024 as against net loss of Rs 1.23 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live

11 months agoCapital Market - Live

Corporate

Kobo Biotech to discuss results

Kobo Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

What is the share price of KOBO Biotech Ltd (KOBO) today?
The share price of KOBO as on 16th July 2025 is ₹2.64. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on KOBO Biotech Ltd (KOBO) share?
The past returns of KOBO Biotech Ltd (KOBO) share are
- Past 1 week: 10.00%
- Past 1 month: N/A%
- Past 3 months: -8.62%
- Past 6 months: -29.14%
- Past 1 year: -37.35%
- Past 3 years: -43.13%
- Past 5 years: -32.40%
What are the peers or stocks similar to KOBO Biotech Ltd (KOBO)?
The peers or stocks similar to KOBO Biotech Ltd (KOBO) include:
What is the market cap of KOBO Biotech Ltd (KOBO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of KOBO Biotech Ltd (KOBO) is ₹6.31 Cr as of 16th July 2025.
What is the 52 week high and low of KOBO Biotech Ltd (KOBO) share?
The 52-week high of KOBO Biotech Ltd (KOBO) is ₹4.56 and the 52-week low is ₹2.32.
What is the PE and PB ratio of KOBO Biotech Ltd (KOBO) stock?
The P/E (price-to-earnings) ratio of KOBO Biotech Ltd (KOBO) is -1.28. The P/B (price-to-book) ratio is -0.05.
Which sector does KOBO Biotech Ltd (KOBO) belong to?
KOBO Biotech Ltd (KOBO) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy KOBO Biotech Ltd (KOBO) shares?
You can directly buy KOBO Biotech Ltd (KOBO) shares on Tickertape. Simply sign up, connect your demat account and place your order.